register

Leadership & Management

Entrepreneurial leadership, breaking new barriers

Health Industry Hub | May 10, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the Pharma, MedTech and Biotech sectors by celebrating and sharing the journey of inspirational and passionate women leaders in the industry.

Lauren Barber, an experienced nurse and entrepreneur, recently launched a novel medtech to ‘close the gate’ on vaccinations. The technology is a game-changer and can be used in an estimated 76 million needle procedures in Australia each year.

In this episode, we dive into the two critical traits empowering women on their leadership journey, the most defining moment in Lauren’s leadership journey, overcoming the fear factor, and more.

As the past Chair of Medical Technology Association of Australia (MTAA) Women in MedTech committee, Lauren also addressees the gender pay gap raised in a recent report.

Podcast

About Lauren Barber

Lauren Barber is a Clinical Nurse Specialist with post graduate qualifications in Healthcare Leadership and Cosmetic Dermatology. Throughout her nursing career Lauren has held various leadership and management roles including clinical supervision and nurse unit manager.

As an entrepreneur, Lauren is the founder and managing director of start-up medical device company NeedleCalm Pty Ltd. She divides her time between developing and commercialising an innovative medical device with leadership roles with the Medical Technology Association of Australia as both previously a Board Member and Chair of the Women in MedTech Committee.

Earlier in her career whilst nursing in emergency departments, Lauren saw the effects that the fear and phobia of needles had on patients and staff and the consequences of healthcare avoidance. This led her to develop a technique of injection to reduce the pain and discomfort associated with needle-related procedures. Since 2016 Lauren has worked to transfer this method of injection into a product, recently launched, for use in patients around the world.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.